Bioqual, Inc. engages in the provision and development of medical research and consulting services to commercial clients and government laboratories. The company is headquartered in Rockville, Maryland. The company also performs in vitro contract research services. The company is involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. Its services also encompass sample processing and custom assays for serology, cell-mediated immunity, viral loads, and bacterial enumeration. Its additional services include advanced biocontainment (BSL3), imaging services, animal model development, and IND-enabling services. Its lab services include cell-based assays, immunoassays, toxicity and cytotoxicity testing, viral load testing, and tailored assay development.
BIOQ stock price ended at $32.5 on 星期四, after rising 0.00%
On the latest trading day Jun 11, 2026, the stock price of BIOQ rose by 0.00%, climbing from $32.50 to $32.50. Throughout the session, the stock experienced a volatility of 0.00%, with prices fluctuating between a daily low of $32.50 and a high of $32.50. Alongside this price increase, trading volume also rose by 125 shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 1.2K shares were traded, amounting to a market value of approximately $28.9M.